Under-Representation and Under-Reporting of Minoritized Racial and Ethnic Groups in Clinical Trials on Immune Checkpoint Inhibitors
Disparities in the representation and reporting of minoritized racial/ethnic groups persist in recent trials on ICIs, necessitating collaborative efforts for improved diversity and equitable cancer treatment access.
Authors
- Haiyang Sheng (ORCID: https://orcid.org/0000-0002-7014-3555)
- E. W. Liang (ORCID: https://orcid.org/0009-0007-2239-3625)
- Song Yao (ORCID: https://orcid.org/0000-0001-9442-1313)
- Jennifer Delmerico (ORCID: https://orcid.org/0000-0001-5475-5829)
- Christine B. Ambrosone (ORCID: https://orcid.org/0000-0003-1717-9943)
- Charles Stewart Kamen (ORCID: https://orcid.org/0000-0002-4219-4320)
- Lori C. Sakoda (ORCID: https://orcid.org/0000-0002-0900-5735)
- Alfredo V. Chua (ORCID: https://orcid.org/0000-0002-0895-8139)
- Igor Puzanov (ORCID: https://orcid.org/0000-0002-9803-3497)
- Prantesh Jain (ORCID: https://orcid.org/0000-0003-2771-4612)
- Gary R. Morrow (ORCID: https://orcid.org/0000-0002-7506-926X)
- Xin-Wei Huang (ORCID: https://orcid.org/0000-0003-4238-3081)
- Shipra Gandhi (ORCID: https://orcid.org/0000-0003-3506-0284)
- Yan Li (ORCID: https://orcid.org/0000-0003-1963-839X)
Institutions
- Roswell Park Comprehensive Cancer Center (US)
- Kaiser Permanente (US)
- University of Rochester Medical Center (US)
- University at Buffalo, State University of New York (US)
Publication Details
- Journal
- JCO Oncology Practice
- Published
- 2024-08-22
- DOI
- https://doi.org/10.1200/op.24.00033
- Citations
- 7
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 2.00